S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NWBO Northwest Biotherapeutics Inc (QB)

0.251

-0.00067 (-0.26%)

08 Mar 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Northwest Biotherapeutics (QB) Charts.

Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Northwest Biotherapeutics (QB) Charts.

Northwest Biotherapeutics Inc (QB) News

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments
Tuesday 14 January 2025 (2 months ago) • AllPennyStocks.com

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 27 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 2 November 2024 (4 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 4 September 2024 (6 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 14 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 10 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 9 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 3 August 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 31 July 2024 (7 months ago) • Edgar (US Regulatory)

Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher
Tuesday 18 June 2024 (9 months ago) • AllPennyStocks.com

More Northwest Biotherapeutics Inc (QB) News Articles

Titanium Transportation

BRPR Corporate Offices R...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions